TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $51,000 | -82.9% | 105,414 | -52.8% | 0.00% | – |
| Q1 2019 | $299,000 | +26.2% | 223,141 | +6.6% | 0.00% | – |
| Q4 2018 | $237,000 | -59.1% | 209,353 | -0.3% | 0.00% | – |
| Q3 2018 | $580,000 | -44.0% | 210,003 | -27.6% | 0.00% | – |
| Q2 2018 | $1,035,000 | +40.2% | 289,970 | +20.5% | 0.00% | – |
| Q1 2018 | $738,000 | -50.1% | 240,638 | +2.5% | 0.00% | – |
| Q4 2017 | $1,480,000 | -8.0% | 234,864 | -0.2% | 0.00% | – |
| Q3 2017 | $1,609,000 | +16.3% | 235,309 | +21.2% | 0.00% | – |
| Q2 2017 | $1,384,000 | -19.8% | 194,144 | +3.3% | 0.00% | – |
| Q1 2017 | $1,726,000 | +135.8% | 187,897 | +3.4% | 0.00% | – |
| Q4 2016 | $732,000 | +28.6% | 181,783 | +22.5% | 0.00% | – |
| Q3 2016 | $569,000 | -22.9% | 148,369 | -13.5% | 0.00% | – |
| Q2 2016 | $738,000 | -21.3% | 171,552 | -15.4% | 0.00% | – |
| Q1 2016 | $938,000 | -42.3% | 202,667 | +25.1% | 0.00% | – |
| Q4 2015 | $1,626,000 | +36.5% | 162,039 | +1.5% | 0.00% | – |
| Q3 2015 | $1,191,000 | -89.1% | 159,678 | -30.7% | 0.00% | -100.0% |
| Q2 2015 | $10,937,000 | +48.1% | 230,528 | +14.4% | 0.00% | +50.0% |
| Q1 2015 | $7,383,000 | +2.5% | 201,507 | +11.1% | 0.00% | 0.0% |
| Q4 2014 | $7,204,000 | +146.5% | 181,424 | +23.8% | 0.00% | +100.0% |
| Q3 2014 | $2,923,000 | +22.6% | 146,541 | -17.1% | 0.00% | – |
| Q2 2014 | $2,384,000 | +226.6% | 176,712 | +163.6% | 0.00% | – |
| Q1 2014 | $730,000 | +1.0% | 67,036 | +25.4% | 0.00% | – |
| Q4 2013 | $723,000 | -2.6% | 53,477 | -18.0% | 0.00% | – |
| Q3 2013 | $742,000 | +222.6% | 65,252 | +99.2% | 0.00% | – |
| Q2 2013 | $230,000 | – | 32,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 317,900 | $11,647,000 | 4.28% |
| Opaleye Management Inc. | 175,000 | $6,412,000 | 2.98% |
| Graticule Asia Macro Advisors LLC | 413,200 | $15,139,000 | 2.02% |
| BB BIOTECH AG | 1,477,114 | $54,121,000 | 1.61% |
| Iguana Healthcare Management, LLC | 75,000 | $2,748,000 | 1.16% |
| Granite Point Capital Management, L.P. | 79,250 | $2,904,000 | 1.06% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 458,202 | $16,788,000 | 0.89% |
| Ghost Tree Capital, LLC | 130,000 | $4,764,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 605,393 | $22,182,000 | 0.84% |
| HealthCor Management, L.P. | 467,200 | $17,118,000 | 0.82% |